Inactive Instrument

Jelsa d.d. Stock

Equities

Duration

Period

Style

Jelsa d.d. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-09-13	CI
Bohemian Financing Zrt. agreed to acquire 1.50065% stake in Jelsa d.d. €0.01 million.	23-03-21	CI
Jelsa d.d. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-27	CI
Jelsa d.d. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-27	CI
Jelsa d.d. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-30	CI
Jelsa d.d. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Jelsa d.d. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-28	CI
Eurobridge Medical Innovation acquired 81.99% stake in Jelsa d.d..	21-03-04	CI
Jelsa d.d. Announces Executive Changes	21-02-02	CI

Jelsa d d : Issuer under observation	23-06-18	PU
Jelsa d d : Due to the proposed decision to the General Assembly regarding delisting Company's shares from the regulated market of ZSE	23-05-11	PU
Jelsa d d : Due to the obligation to announce the takeover bid of JELSA d.d. by BOHEMIAN FINANCING ZRT	23-03-24	PU

Managers	Title	Age	Since
László Péter Gnadig CEO	Chief Executive Officer	-	23-04-10
Kornél Bodnár PRN	Corporate Officer/Principal	-	23-04-10
Anton Glumac PRN	Corporate Officer/Principal	-	21-11-04

Members of the board	Title	Age	Since
Dániel Jellinek CHM	Chairman	47	23-04-10
Tamás Szöllosi BRD	Director/Board Member	-	23-04-10
Szabolcs Mestyán BRD	Director/Board Member	-	23-06-18

Sector